Authors:
Martinez, C
Garcia-Martin, E
Ladero, JM
Sastre, J
Garcia-Gamito, F
Diaz-Rubio, M
Agundez, JAG
Citation: C. Martinez et al., Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk, CARCINOGENE, 22(8), 2001, pp. 1323-1326
Authors:
Garcia-Martin, E
Martinez, C
Ladero, JM
Gamito, FJG
Agundez, JAG
Citation: E. Garcia-martin et al., High frequency of mutations related to impaired CYP2C9 metabolism in a Caucasian population, EUR J CL PH, 57(1), 2001, pp. 47-49
Authors:
Agundez, JAG
Gallardo, L
Ledesma, MC
Lozano, L
Rodriguez-Lescure, A
Pontes, JC
Iglesias-Moreno, MC
Poch, J
Ladero, JM
Benitez, J
Citation: Jag. Agundez et al., Functionally active duplications of the CYP2D6 gene are more prevalent among larynx and lung cancer patients, ONCOL-BASEL, 61(1), 2001, pp. 59-63
Authors:
Marcus, PM
Hayes, RB
Vineis, P
Garcia-Closas, M
Caporaso, NE
Autrup, H
Branch, RA
Brockmoller, J
Ishizaki, T
Karakaya, AE
Ladero, JM
Mommsen, S
Okkels, H
Romkes, M
Roots, I
Rothman, N
Citation: Pm. Marcus et al., Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: A case-series meta-analysis of a gene-environment interaction, CANC EPID B, 9(5), 2000, pp. 461-467
Authors:
Agundez, JAG
Lozano, L
Ladero, JM
Sastre, J
Cerdan, FJ
Diaz-Rubio, M
Benitez, J
Citation: Jag. Agundez et al., N-acetyltransferase 2 (NAT2) genotype and colorectal carcinoma: Risk variability according to tumour site?, SC J GASTR, 35(10), 2000, pp. 1087-1091
Authors:
Agundez, JAG
Jimenez-Jimenez, FJ
Luengo, A
Molina, JA
Orti-Pareja, M
Vazquez, A
Ramos, F
Duarte, J
Coria, F
Ladero, JM
Alvarez-Cermeno, JC
Benitez, J
Citation: Jag. Agundez et al., Slow allotypic variants of the NAT2 gene and susceptibility to early-onsetParkinson's disease, NEUROLOGY, 51(6), 1998, pp. 1587-1592